Contact
Please use this form to send email to PR contact of this press release:
Orphan designation: Ziftomenib Treatment of acute myeloid leukaemia, 12/01/2024 Positive
TO:
Please use this form to send email to PR contact of this press release:
Orphan designation: Ziftomenib Treatment of acute myeloid leukaemia, 12/01/2024 Positive
TO: